Stephen Richardson at [NYU Langone Medical Center]

Stephen B. Richardson, MD

  • Specialty: Endocrinology
  • Language: English
  • Phone: 212-481-1350

About Me

Conditions and Treatments

pituitary adenoma, thyroid diseases, osteoporosis, hypogonadotropic hypogonadism, galactorrhea, hypopituitarism, pituitary tumor, diabetes insipidus, prolactinoma, craniopharyngioma, pituitary disorders, parathyroid disease, subacute thyroiditis, diabetes, cushing's syndrome, hyperparathyroidism, metabolic bone disease, insulin dependent diabetes, neuroendocrine tumor, acromegaly
Show More Conditions


  • Associate Professor, Department of Medicine
Board Certifications
  • American Board of Internal Medicine (Endocrinology, Diabetes & Metabolism), 1983
  • American Board of Internal Medicine - Internal Medicine, 1981
Education and Training
  • Fellowship, NYU Medical Center, Endocrinology, 1978
  • MD from Kings College, 1971

Locations and Appointments

530 First Avenue
New York, NY 10016


Phone: 212-481-1350

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

My Research

We investigate the regulation of insulin secretion i. in the physiological state ii. in noninsulin-dependent diabetes in which insulin secretion is defective and pancreatic beta cells fail to respond to glucose. We found that the pancreas contains immunoreactive vasopressin (VP)-like material, that VP is a powerful and unique insulin secretagogue able to stimulate secretion in the absence of glucose while potentiating glucose-induced insulin secretion, and that beta cells express VP receptors which strongly resemble corticotrophic V1b receptors. We are characterizing the beta cell V1 receptor by PCR to determine whether it belongs to the V1b-type or represents a novel subclass of VP receptor.

We also study the role of the GH-IGF1 axis in the development of diabetic retinopathy. Using endothelial cell lines and umbilical vein endothelial cells, we research the signal transduction pathways stimulated by angiogenic growth factors and their interactions with known or putative inhibitors of angiogenesis and endothelial proliferation such as somatostatin and its analogs.


  • Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus

    Bruehl, Hannah; Wolf, Oliver T; Sweat, Victoria; Tirsi, Aziz; Richardson, Stephen; Convit, Antonio
    Brain research. 2009 Jul 14. 1280: 186-194

  • Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes

    Gold, S M; Dziobek, I; Sweat, V; Tirsi, A; Rogers, K; Bruehl, H; Tsui, W; Richardson, S; Javier, E; Convit, A
    Diabetologia. 2007 Apr. 50 (4): 711-719

  • The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus

    Albrecht, Joerg; Taylor, Lynne; Berlin, Jesse A; Dulay, Samuel; Ang, Gina; Fakharzadeh, Steven; Kantor, Jonathan; Kim, Ellen; Militello, Giuseppe; McGinnis, Karen; Richardson, Stephen; Treat, James; Vittorio, Carmela; Van Voorhees, Abby; Werth, Victoria P
    Journal of investigative dermatology. 2005 Nov. 125 (5): 889-894

Read All Publications (43)